Lancet Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
1
- Investments
-
9
- Portfolio
-
1
- Exits
-
5
Lancet Capital General Information
Company Description
Founded in 1998, Lancet Capital is a venture capital investment firm based in Boston, Massachusetts. The firm seeks to invest in biomedical technologies, bio-informatics, biopharmaceuticals, medical devices, medical information systems, medical therapeutics, and diagnostic systems.
Business Details
Website
www.lancetcapital.wordpress.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 52 Richwood Street
- Boston, MA 02132
- United States
Lancet Capital Investments (9)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Noveome Biotherapeutics | 31-Mar-2025 | Later Stage VC | Biotechnology | Clinical Trials - Phase 2 | ||
| Biodel | 02-Aug-2006 | Drug Discovery | Generating Revenue | |||
| Enanta Pharmaceuticals | 24-Jan-2004 | Biotechnology | Generating Revenue | |||
| Dyax | 14-Mar-2003 | Drug Discovery | Generating Revenue | |||
| Scion Pharmaceuticals | 29-Jul-2002 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Stentor | 19-Oct-2000 | Other Healthcare Technology Systems | Generating Revenue | |||
| Enanta Pharmaceuticals | 28-Jul-2000 | Biotechnology | Generating Revenue | |||
| VivoQuest | 01-Sep-1998 | Seed Round | Discovery Tools (Healthcare) | Generating Revenue | ||
| Stentor | Early Stage VC | Other Healthcare Technology Systems | Generating Revenue |
Lancet Capital Exits (5)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Dyax | 22-Jan-2016 | Merger/Acquisition | |
| Enanta Pharmaceuticals | 21-Mar-2013 | ||
| VivoQuest | 20-Sep-2005 | ||
| Stentor | 05-Aug-2005 | Merger/Acquisition | |
| Scion Pharmaceuticals | 17-Jun-2005 | Merger/Acquisition |
Lancet Capital Investments by Industry, Year, and Region
Lancet Capital Co-Investors (8)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Carnegie Mellon University | 1 |
|
|
||
| Commonwealth of Pennsylvania |
|
|
|||
| MAK Capital |
|
|
|||
| Miraki Innovation |
|
|
|||
| University of Pittsburgh Endowment |
|
|
Lancet Capital FAQs
-
What is Lancet Capital?
Founded in 1998, Lancet Capital is a venture capital investment firm based in Boston, Massachusetts.
-
When was Lancet Capital founded?
Lancet Capital was founded in 1998.
-
Where is Lancet Capital headquartered?
Lancet Capital is headquartered in Boston, MA.
-
How many investments has Lancet Capital made?
Lancet Capital has made 9 investments.
-
What has Lancet Capital invested in?
Lancet Capital has made numerous investments in companies like Noveome Biotherapeutics, Biodel, and Enanta Pharmaceuticals within the Biotechnology and Drug Discovery industries.
-
What has Lancet Capital invested in recently?
Lancet Capital's latest investment was on 31-Mar-2025 in Noveome Biotherapeutics, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process